Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 75

1.

In vivo adaptation of hepatitis C virus in chimpanzees for efficient virus production and evasion of apoptosis.

Saeed M, Shiina M, Date T, Akazawa D, Watanabe N, Murayama A, Suzuki T, Watanabe H, Hiraga N, Imamura M, Chayama K, Choi Y, Krawczynski K, Liang TJ, Wakita T, Kato T.

Hepatology. 2011 Aug;54(2):425-33. doi: 10.1002/hep.24399. Epub 2011 Jun 26.

2.

Hepatitis C virus JFH-1 strain infection in chimpanzees is associated with low pathogenicity and emergence of an adaptive mutation.

Kato T, Choi Y, Elmowalid G, Sapp RK, Barth H, Furusaka A, Mishiro S, Wakita T, Krawczynski K, Liang TJ.

Hepatology. 2008 Sep;48(3):732-40. doi: 10.1002/hep.22422.

3.

Amino Acid Mutations in the NS4A Region of Hepatitis C Virus Contribute to Viral Replication and Infectious Virus Production.

Murayama A, Sugiyama N, Suzuki R, Moriyama M, Nakamura N, Mochizuki H, Wakita T, Kato T.

J Virol. 2017 Jan 31;91(4). pii: e02124-16. doi: 10.1128/JVI.02124-16. Print 2017 Feb 15.

4.

Single strain isolation method for cell culture-adapted hepatitis C virus by end-point dilution and infection.

Sugiyama N, Murayama A, Suzuki R, Watanabe N, Shiina M, Liang TJ, Wakita T, Kato T.

PLoS One. 2014 May 21;9(5):e98168. doi: 10.1371/journal.pone.0098168. eCollection 2014.

5.

A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.

Sa-Ngiamsuntorn K, Wongkajornsilp A, Phanthong P, Borwornpinyo S, Kitiyanant N, Chantratita W, Hongeng S.

Virol J. 2016 Apr 5;13:59. doi: 10.1186/s12985-016-0519-1.

6.

Cell culture and infection system for hepatitis C virus.

Kato T, Date T, Murayama A, Morikawa K, Akazawa D, Wakita T.

Nat Protoc. 2006;1(5):2334-9.

PMID:
17406476
7.

Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.

Zhu H, Dong H, Eksioglu E, Hemming A, Cao M, Crawford JM, Nelson DR, Liu C.

Gastroenterology. 2007 Nov;133(5):1649-59. Epub 2007 Sep 16.

PMID:
17983809
8.

Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees.

Bukh J, Pietschmann T, Lohmann V, Krieger N, Faulk K, Engle RE, Govindarajan S, Shapiro M, St Claire M, Bartenschlager R.

Proc Natl Acad Sci U S A. 2002 Oct 29;99(22):14416-21. Epub 2002 Oct 21.

9.

A subclone of HuH-7 with enhanced intracellular hepatitis C virus production and evasion of virus related-cell cycle arrest.

Murayama A, Sugiyama N, Yoshimura S, Ishihara-Sugano M, Masaki T, Kim S, Wakita T, Mishiro S, Kato T.

PLoS One. 2012;7(12):e52697. doi: 10.1371/journal.pone.0052697. Epub 2012 Dec 20.

10.

Patient-derived hepatitis C virus and JFH-1 clones differ in their ability to infect human hepatoma cells and lymphocytes.

Sarhan MA, Chen AY, Russell RS, Michalak TI.

J Gen Virol. 2012 Nov;93(Pt 11):2399-407. doi: 10.1099/vir.0.045393-0. Epub 2012 Aug 1.

PMID:
22855787
11.

Production of infectious hepatitis C virus of various genotypes in cell cultures.

Kato T, Matsumura T, Heller T, Saito S, Sapp RK, Murthy K, Wakita T, Liang TJ.

J Virol. 2007 May;81(9):4405-11. Epub 2007 Feb 14.

12.

A laboratory-adapted HCV JFH-1 strain is sensitive to neutralization and can gradually escape under the selection pressure of neutralizing human plasma.

Song H, Ren F, Li J, Shi S, Yan L, Gao F, Li K, Zhuang H.

Virus Res. 2012 Oct;169(1):154-61. doi: 10.1016/j.virusres.2012.07.022. Epub 2012 Jul 27.

PMID:
22846920
13.

[Production of infectious hepatitis C virus in cell culture].

Kato T, Wakita T.

Uirusu. 2005 Dec;55(2):287-95. Review. Japanese.

14.

Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77.

Li YP, Ramirez S, Mikkelsen L, Bukh J.

J Virol. 2015 Jan;89(1):811-23. doi: 10.1128/JVI.02877-14. Epub 2014 Oct 29.

15.

An infectious and selectable full-length replicon system with hepatitis C virus JFH-1 strain.

Date T, Miyamoto M, Kato T, Morikawa K, Murayama A, Akazawa D, Tanabe J, Sone S, Mizokami M, Wakita T.

Hepatol Res. 2007 Jun;37(6):433-43. Epub 2007 Apr 16.

PMID:
17437527
16.

Novel cell culture-adapted genotype 2a hepatitis C virus infectious clone.

Date T, Kato T, Kato J, Takahashi H, Morikawa K, Akazawa D, Murayama A, Tanaka-Kaneko K, Sata T, Tanaka Y, Mizokami M, Wakita T.

J Virol. 2012 Oct;86(19):10805-20. doi: 10.1128/JVI.07235-11. Epub 2012 Jul 11.

17.

Production of infectious chimeric hepatitis C virus genotype 2b harboring minimal regions of JFH-1.

Murayama A, Kato T, Akazawa D, Sugiyama N, Date T, Masaki T, Nakamoto S, Tanaka Y, Mizokami M, Yokosuka O, Nomoto A, Wakita T.

J Virol. 2012 Feb;86(4):2143-52. doi: 10.1128/JVI.05386-11. Epub 2011 Dec 7.

18.

Development of hepatitis C virus production reporter-assay systems using two different hepatoma cell lines.

Takeda M, Ikeda M, Ariumi Y, Wakita T, Kato N.

J Gen Virol. 2012 Jul;93(Pt 7):1422-31. doi: 10.1099/vir.0.040725-0. Epub 2012 Mar 28.

PMID:
22456614
19.

Virological characterization of the hepatitis C virus JFH-1 strain in lymphocytic cell lines.

Murakami K, Kimura T, Osaki M, Ishii K, Miyamura T, Suzuki T, Wakita T, Shoji I.

J Gen Virol. 2008 Jul;89(Pt 7):1587-92. doi: 10.1099/vir.0.83618-0.

PMID:
18559928
20.

Two methods of heterokaryon formation to discover HCV restriction factors.

Frentzen A, Hueging K, Bitzegeio J, Pietschmann T, Steinmann E.

J Vis Exp. 2012 Jul 16;(65):e4029. doi: 10.3791/4029.

Supplemental Content

Support Center